Global Expectorant Drug Supply, Demand and Key Producers, 2024-2030
The global Expectorant Drug market size is expected to reach $ 524.2 million by 2030, rising at a market growth of 6.6% CAGR during the forecast period (2024-2030).
Growing Respiratory Disorders: With increasing pollution levels, smoking habits, and respiratory infections, the prevalence of respiratory disorders such as bronchitis, COPD (Chronic Obstructive Pulmonary Disease), and asthma is rising globally. This drives the demand for expectorant drugs as they help in clearing mucus from the respiratory tract.Preference for Natural Remedies: There's a growing trend towards natural and herbal expectorants as people become more health-conscious and seek alternatives to conventional medication. This trend might impact the market share of synthetic expectorants.Technological Advancements: Pharmaceutical companies are continuously investing in research and development to introduce more effective and safer expectorant formulations. This includes innovations in drug delivery systems to enhance the efficacy and convenience of expectorant medications.
This report studies the global Expectorant Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Expectorant Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Expectorant Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Expectorant Drug total production and demand, 2019-2030, (K Units)
Global Expectorant Drug total production value, 2019-2030, (USD Million)
Global Expectorant Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Expectorant Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Expectorant Drug domestic production, consumption, key domestic manufacturers and share
Global Expectorant Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Expectorant Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Expectorant Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Expectorant Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Acella Pharmaceuticals LLC, Astrazeneca Plc., Cipla Limited, Dabur India Ltd, Glenmark Pharmaceuticals Limited, lohnson and Johnson, Merck KGaA and Novartis International AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Expectorant Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Expectorant Drug Market, By Region:
1. How big is the global Expectorant Drug market?
2. What is the demand of the global Expectorant Drug market?
3. What is the year over year growth of the global Expectorant Drug market?
4. What is the production and production value of the global Expectorant Drug market?
5. Who are the key producers in the global Expectorant Drug market?
Growing Respiratory Disorders: With increasing pollution levels, smoking habits, and respiratory infections, the prevalence of respiratory disorders such as bronchitis, COPD (Chronic Obstructive Pulmonary Disease), and asthma is rising globally. This drives the demand for expectorant drugs as they help in clearing mucus from the respiratory tract.Preference for Natural Remedies: There's a growing trend towards natural and herbal expectorants as people become more health-conscious and seek alternatives to conventional medication. This trend might impact the market share of synthetic expectorants.Technological Advancements: Pharmaceutical companies are continuously investing in research and development to introduce more effective and safer expectorant formulations. This includes innovations in drug delivery systems to enhance the efficacy and convenience of expectorant medications.
This report studies the global Expectorant Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Expectorant Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Expectorant Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Expectorant Drug total production and demand, 2019-2030, (K Units)
Global Expectorant Drug total production value, 2019-2030, (USD Million)
Global Expectorant Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Expectorant Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Expectorant Drug domestic production, consumption, key domestic manufacturers and share
Global Expectorant Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Expectorant Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Expectorant Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Expectorant Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Acella Pharmaceuticals LLC, Astrazeneca Plc., Cipla Limited, Dabur India Ltd, Glenmark Pharmaceuticals Limited, lohnson and Johnson, Merck KGaA and Novartis International AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Expectorant Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Expectorant Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oral Solid
- Oral Liquid
- Inhalants
- Hospital
- Clinic
- Other
- Abbott Laboratories
- Acella Pharmaceuticals LLC
- Astrazeneca Plc.
- Cipla Limited
- Dabur India Ltd
- Glenmark Pharmaceuticals Limited
- lohnson and Johnson
- Merck KGaA
- Novartis International AG
- Pfizer Inc.
- Proctor and Gamble Co
- Reckitt Benckiser Group plc
- Sanofi SA
- The Himalaya Drug Company
- Perrigo Company plc
- Vernalis plc
- Tris Pharma Inc.
- Aytu BioScience Inc.
- Mayne Pharma Inc.
- Taro Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC
- Aurobindo Pharma Ltd
- GlaxoSmithKline plc.
1. How big is the global Expectorant Drug market?
2. What is the demand of the global Expectorant Drug market?
3. What is the year over year growth of the global Expectorant Drug market?
4. What is the production and production value of the global Expectorant Drug market?
5. Who are the key producers in the global Expectorant Drug market?
1 SUPPLY SUMMARY
1.1 Expectorant Drug Introduction
1.2 World Expectorant Drug Supply & Forecast
1.2.1 World Expectorant Drug Production Value (2019 & 2023 & 2030)
1.2.2 World Expectorant Drug Production (2019-2030)
1.2.3 World Expectorant Drug Pricing Trends (2019-2030)
1.3 World Expectorant Drug Production by Region (Based on Production Site)
1.3.1 World Expectorant Drug Production Value by Region (2019-2030)
1.3.2 World Expectorant Drug Production by Region (2019-2030)
1.3.3 World Expectorant Drug Average Price by Region (2019-2030)
1.3.4 North America Expectorant Drug Production (2019-2030)
1.3.5 Europe Expectorant Drug Production (2019-2030)
1.3.6 China Expectorant Drug Production (2019-2030)
1.3.7 Japan Expectorant Drug Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Expectorant Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Expectorant Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Expectorant Drug Demand (2019-2030)
2.2 World Expectorant Drug Consumption by Region
2.2.1 World Expectorant Drug Consumption by Region (2019-2024)
2.2.2 World Expectorant Drug Consumption Forecast by Region (2025-2030)
2.3 United States Expectorant Drug Consumption (2019-2030)
2.4 China Expectorant Drug Consumption (2019-2030)
2.5 Europe Expectorant Drug Consumption (2019-2030)
2.6 Japan Expectorant Drug Consumption (2019-2030)
2.7 South Korea Expectorant Drug Consumption (2019-2030)
2.8 ASEAN Expectorant Drug Consumption (2019-2030)
2.9 India Expectorant Drug Consumption (2019-2030)
3 WORLD EXPECTORANT DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Expectorant Drug Production Value by Manufacturer (2019-2024)
3.2 World Expectorant Drug Production by Manufacturer (2019-2024)
3.3 World Expectorant Drug Average Price by Manufacturer (2019-2024)
3.4 Expectorant Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Expectorant Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Expectorant Drug in 2023
3.5.3 Global Concentration Ratios (CR8) for Expectorant Drug in 2023
3.6 Expectorant Drug Market: Overall Company Footprint Analysis
3.6.1 Expectorant Drug Market: Region Footprint
3.6.2 Expectorant Drug Market: Company Product Type Footprint
3.6.3 Expectorant Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Expectorant Drug Production Value Comparison
4.1.1 United States VS China: Expectorant Drug Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Expectorant Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Expectorant Drug Production Comparison
4.2.1 United States VS China: Expectorant Drug Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Expectorant Drug Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Expectorant Drug Consumption Comparison
4.3.1 United States VS China: Expectorant Drug Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Expectorant Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Expectorant Drug Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Expectorant Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Expectorant Drug Production Value (2019-2024)
4.4.3 United States Based Manufacturers Expectorant Drug Production (2019-2024)
4.5 China Based Expectorant Drug Manufacturers and Market Share
4.5.1 China Based Expectorant Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Expectorant Drug Production Value (2019-2024)
4.5.3 China Based Manufacturers Expectorant Drug Production (2019-2024)
4.6 Rest of World Based Expectorant Drug Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Expectorant Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Expectorant Drug Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Expectorant Drug Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Expectorant Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Oral Solid
5.2.2 Oral Liquid
5.2.3 Inhalants
5.3 Market Segment by Type
5.3.1 World Expectorant Drug Production by Type (2019-2030)
5.3.2 World Expectorant Drug Production Value by Type (2019-2030)
5.3.3 World Expectorant Drug Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Expectorant Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Expectorant Drug Production by Application (2019-2030)
6.3.2 World Expectorant Drug Production Value by Application (2019-2030)
6.3.3 World Expectorant Drug Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Details
7.1.2 Abbott Laboratories Major Business
7.1.3 Abbott Laboratories Expectorant Drug Product and Services
7.1.4 Abbott Laboratories Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Abbott Laboratories Recent Developments/Updates
7.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.2 Acella Pharmaceuticals LLC
7.2.1 Acella Pharmaceuticals LLC Details
7.2.2 Acella Pharmaceuticals LLC Major Business
7.2.3 Acella Pharmaceuticals LLC Expectorant Drug Product and Services
7.2.4 Acella Pharmaceuticals LLC Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Acella Pharmaceuticals LLC Recent Developments/Updates
7.2.6 Acella Pharmaceuticals LLC Competitive Strengths & Weaknesses
7.3 Astrazeneca Plc.
7.3.1 Astrazeneca Plc. Details
7.3.2 Astrazeneca Plc. Major Business
7.3.3 Astrazeneca Plc. Expectorant Drug Product and Services
7.3.4 Astrazeneca Plc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Astrazeneca Plc. Recent Developments/Updates
7.3.6 Astrazeneca Plc. Competitive Strengths & Weaknesses
7.4 Cipla Limited
7.4.1 Cipla Limited Details
7.4.2 Cipla Limited Major Business
7.4.3 Cipla Limited Expectorant Drug Product and Services
7.4.4 Cipla Limited Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Cipla Limited Recent Developments/Updates
7.4.6 Cipla Limited Competitive Strengths & Weaknesses
7.5 Dabur India Ltd
7.5.1 Dabur India Ltd Details
7.5.2 Dabur India Ltd Major Business
7.5.3 Dabur India Ltd Expectorant Drug Product and Services
7.5.4 Dabur India Ltd Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Dabur India Ltd Recent Developments/Updates
7.5.6 Dabur India Ltd Competitive Strengths & Weaknesses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Glenmark Pharmaceuticals Limited Details
7.6.2 Glenmark Pharmaceuticals Limited Major Business
7.6.3 Glenmark Pharmaceuticals Limited Expectorant Drug Product and Services
7.6.4 Glenmark Pharmaceuticals Limited Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Glenmark Pharmaceuticals Limited Recent Developments/Updates
7.6.6 Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.7 lohnson and Johnson
7.7.1 lohnson and Johnson Details
7.7.2 lohnson and Johnson Major Business
7.7.3 lohnson and Johnson Expectorant Drug Product and Services
7.7.4 lohnson and Johnson Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 lohnson and Johnson Recent Developments/Updates
7.7.6 lohnson and Johnson Competitive Strengths & Weaknesses
7.8 Merck KGaA
7.8.1 Merck KGaA Details
7.8.2 Merck KGaA Major Business
7.8.3 Merck KGaA Expectorant Drug Product and Services
7.8.4 Merck KGaA Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Merck KGaA Recent Developments/Updates
7.8.6 Merck KGaA Competitive Strengths & Weaknesses
7.9 Novartis International AG
7.9.1 Novartis International AG Details
7.9.2 Novartis International AG Major Business
7.9.3 Novartis International AG Expectorant Drug Product and Services
7.9.4 Novartis International AG Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Novartis International AG Recent Developments/Updates
7.9.6 Novartis International AG Competitive Strengths & Weaknesses
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Details
7.10.2 Pfizer Inc. Major Business
7.10.3 Pfizer Inc. Expectorant Drug Product and Services
7.10.4 Pfizer Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Pfizer Inc. Recent Developments/Updates
7.10.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.11 Proctor and Gamble Co
7.11.1 Proctor and Gamble Co Details
7.11.2 Proctor and Gamble Co Major Business
7.11.3 Proctor and Gamble Co Expectorant Drug Product and Services
7.11.4 Proctor and Gamble Co Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Proctor and Gamble Co Recent Developments/Updates
7.11.6 Proctor and Gamble Co Competitive Strengths & Weaknesses
7.12 Reckitt Benckiser Group plc
7.12.1 Reckitt Benckiser Group plc Details
7.12.2 Reckitt Benckiser Group plc Major Business
7.12.3 Reckitt Benckiser Group plc Expectorant Drug Product and Services
7.12.4 Reckitt Benckiser Group plc Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Reckitt Benckiser Group plc Recent Developments/Updates
7.12.6 Reckitt Benckiser Group plc Competitive Strengths & Weaknesses
7.13 Sanofi SA
7.13.1 Sanofi SA Details
7.13.2 Sanofi SA Major Business
7.13.3 Sanofi SA Expectorant Drug Product and Services
7.13.4 Sanofi SA Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Sanofi SA Recent Developments/Updates
7.13.6 Sanofi SA Competitive Strengths & Weaknesses
7.14 The Himalaya Drug Company
7.14.1 The Himalaya Drug Company Details
7.14.2 The Himalaya Drug Company Major Business
7.14.3 The Himalaya Drug Company Expectorant Drug Product and Services
7.14.4 The Himalaya Drug Company Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 The Himalaya Drug Company Recent Developments/Updates
7.14.6 The Himalaya Drug Company Competitive Strengths & Weaknesses
7.15 Perrigo Company plc
7.15.1 Perrigo Company plc Details
7.15.2 Perrigo Company plc Major Business
7.15.3 Perrigo Company plc Expectorant Drug Product and Services
7.15.4 Perrigo Company plc Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Perrigo Company plc Recent Developments/Updates
7.15.6 Perrigo Company plc Competitive Strengths & Weaknesses
7.16 Vernalis plc
7.16.1 Vernalis plc Details
7.16.2 Vernalis plc Major Business
7.16.3 Vernalis plc Expectorant Drug Product and Services
7.16.4 Vernalis plc Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Vernalis plc Recent Developments/Updates
7.16.6 Vernalis plc Competitive Strengths & Weaknesses
7.17 Tris Pharma Inc.
7.17.1 Tris Pharma Inc. Details
7.17.2 Tris Pharma Inc. Major Business
7.17.3 Tris Pharma Inc. Expectorant Drug Product and Services
7.17.4 Tris Pharma Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Tris Pharma Inc. Recent Developments/Updates
7.17.6 Tris Pharma Inc. Competitive Strengths & Weaknesses
7.18 Aytu BioScience Inc.
7.18.1 Aytu BioScience Inc. Details
7.18.2 Aytu BioScience Inc. Major Business
7.18.3 Aytu BioScience Inc. Expectorant Drug Product and Services
7.18.4 Aytu BioScience Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Aytu BioScience Inc. Recent Developments/Updates
7.18.6 Aytu BioScience Inc. Competitive Strengths & Weaknesses
7.19 Mayne Pharma Inc.
7.19.1 Mayne Pharma Inc. Details
7.19.2 Mayne Pharma Inc. Major Business
7.19.3 Mayne Pharma Inc. Expectorant Drug Product and Services
7.19.4 Mayne Pharma Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Mayne Pharma Inc. Recent Developments/Updates
7.19.6 Mayne Pharma Inc. Competitive Strengths & Weaknesses
7.20 Taro Pharmaceutical Industries Ltd.
7.20.1 Taro Pharmaceutical Industries Ltd. Details
7.20.2 Taro Pharmaceutical Industries Ltd. Major Business
7.20.3 Taro Pharmaceutical Industries Ltd. Expectorant Drug Product and Services
7.20.4 Taro Pharmaceutical Industries Ltd. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
7.20.6 Taro Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.21 Amneal Pharmaceuticals LLC
7.21.1 Amneal Pharmaceuticals LLC Details
7.21.2 Amneal Pharmaceuticals LLC Major Business
7.21.3 Amneal Pharmaceuticals LLC Expectorant Drug Product and Services
7.21.4 Amneal Pharmaceuticals LLC Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
7.21.6 Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
7.22 Aurobindo Pharma Ltd
7.22.1 Aurobindo Pharma Ltd Details
7.22.2 Aurobindo Pharma Ltd Major Business
7.22.3 Aurobindo Pharma Ltd Expectorant Drug Product and Services
7.22.4 Aurobindo Pharma Ltd Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.22.5 Aurobindo Pharma Ltd Recent Developments/Updates
7.22.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
7.23 GlaxoSmithKline plc.
7.23.1 GlaxoSmithKline plc. Details
7.23.2 GlaxoSmithKline plc. Major Business
7.23.3 GlaxoSmithKline plc. Expectorant Drug Product and Services
7.23.4 GlaxoSmithKline plc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.23.5 GlaxoSmithKline plc. Recent Developments/Updates
7.23.6 GlaxoSmithKline plc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Expectorant Drug Industry Chain
8.2 Expectorant Drug Upstream Analysis
8.2.1 Expectorant Drug Core Raw Materials
8.2.2 Main Manufacturers of Expectorant Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Expectorant Drug Production Mode
8.6 Expectorant Drug Procurement Model
8.7 Expectorant Drug Industry Sales Model and Sales Channels
8.7.1 Expectorant Drug Sales Model
8.7.2 Expectorant Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Expectorant Drug Introduction
1.2 World Expectorant Drug Supply & Forecast
1.2.1 World Expectorant Drug Production Value (2019 & 2023 & 2030)
1.2.2 World Expectorant Drug Production (2019-2030)
1.2.3 World Expectorant Drug Pricing Trends (2019-2030)
1.3 World Expectorant Drug Production by Region (Based on Production Site)
1.3.1 World Expectorant Drug Production Value by Region (2019-2030)
1.3.2 World Expectorant Drug Production by Region (2019-2030)
1.3.3 World Expectorant Drug Average Price by Region (2019-2030)
1.3.4 North America Expectorant Drug Production (2019-2030)
1.3.5 Europe Expectorant Drug Production (2019-2030)
1.3.6 China Expectorant Drug Production (2019-2030)
1.3.7 Japan Expectorant Drug Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Expectorant Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Expectorant Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Expectorant Drug Demand (2019-2030)
2.2 World Expectorant Drug Consumption by Region
2.2.1 World Expectorant Drug Consumption by Region (2019-2024)
2.2.2 World Expectorant Drug Consumption Forecast by Region (2025-2030)
2.3 United States Expectorant Drug Consumption (2019-2030)
2.4 China Expectorant Drug Consumption (2019-2030)
2.5 Europe Expectorant Drug Consumption (2019-2030)
2.6 Japan Expectorant Drug Consumption (2019-2030)
2.7 South Korea Expectorant Drug Consumption (2019-2030)
2.8 ASEAN Expectorant Drug Consumption (2019-2030)
2.9 India Expectorant Drug Consumption (2019-2030)
3 WORLD EXPECTORANT DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Expectorant Drug Production Value by Manufacturer (2019-2024)
3.2 World Expectorant Drug Production by Manufacturer (2019-2024)
3.3 World Expectorant Drug Average Price by Manufacturer (2019-2024)
3.4 Expectorant Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Expectorant Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Expectorant Drug in 2023
3.5.3 Global Concentration Ratios (CR8) for Expectorant Drug in 2023
3.6 Expectorant Drug Market: Overall Company Footprint Analysis
3.6.1 Expectorant Drug Market: Region Footprint
3.6.2 Expectorant Drug Market: Company Product Type Footprint
3.6.3 Expectorant Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Expectorant Drug Production Value Comparison
4.1.1 United States VS China: Expectorant Drug Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Expectorant Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Expectorant Drug Production Comparison
4.2.1 United States VS China: Expectorant Drug Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Expectorant Drug Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Expectorant Drug Consumption Comparison
4.3.1 United States VS China: Expectorant Drug Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Expectorant Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Expectorant Drug Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Expectorant Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Expectorant Drug Production Value (2019-2024)
4.4.3 United States Based Manufacturers Expectorant Drug Production (2019-2024)
4.5 China Based Expectorant Drug Manufacturers and Market Share
4.5.1 China Based Expectorant Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Expectorant Drug Production Value (2019-2024)
4.5.3 China Based Manufacturers Expectorant Drug Production (2019-2024)
4.6 Rest of World Based Expectorant Drug Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Expectorant Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Expectorant Drug Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Expectorant Drug Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Expectorant Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Oral Solid
5.2.2 Oral Liquid
5.2.3 Inhalants
5.3 Market Segment by Type
5.3.1 World Expectorant Drug Production by Type (2019-2030)
5.3.2 World Expectorant Drug Production Value by Type (2019-2030)
5.3.3 World Expectorant Drug Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Expectorant Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Expectorant Drug Production by Application (2019-2030)
6.3.2 World Expectorant Drug Production Value by Application (2019-2030)
6.3.3 World Expectorant Drug Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Details
7.1.2 Abbott Laboratories Major Business
7.1.3 Abbott Laboratories Expectorant Drug Product and Services
7.1.4 Abbott Laboratories Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Abbott Laboratories Recent Developments/Updates
7.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.2 Acella Pharmaceuticals LLC
7.2.1 Acella Pharmaceuticals LLC Details
7.2.2 Acella Pharmaceuticals LLC Major Business
7.2.3 Acella Pharmaceuticals LLC Expectorant Drug Product and Services
7.2.4 Acella Pharmaceuticals LLC Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Acella Pharmaceuticals LLC Recent Developments/Updates
7.2.6 Acella Pharmaceuticals LLC Competitive Strengths & Weaknesses
7.3 Astrazeneca Plc.
7.3.1 Astrazeneca Plc. Details
7.3.2 Astrazeneca Plc. Major Business
7.3.3 Astrazeneca Plc. Expectorant Drug Product and Services
7.3.4 Astrazeneca Plc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Astrazeneca Plc. Recent Developments/Updates
7.3.6 Astrazeneca Plc. Competitive Strengths & Weaknesses
7.4 Cipla Limited
7.4.1 Cipla Limited Details
7.4.2 Cipla Limited Major Business
7.4.3 Cipla Limited Expectorant Drug Product and Services
7.4.4 Cipla Limited Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Cipla Limited Recent Developments/Updates
7.4.6 Cipla Limited Competitive Strengths & Weaknesses
7.5 Dabur India Ltd
7.5.1 Dabur India Ltd Details
7.5.2 Dabur India Ltd Major Business
7.5.3 Dabur India Ltd Expectorant Drug Product and Services
7.5.4 Dabur India Ltd Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Dabur India Ltd Recent Developments/Updates
7.5.6 Dabur India Ltd Competitive Strengths & Weaknesses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Glenmark Pharmaceuticals Limited Details
7.6.2 Glenmark Pharmaceuticals Limited Major Business
7.6.3 Glenmark Pharmaceuticals Limited Expectorant Drug Product and Services
7.6.4 Glenmark Pharmaceuticals Limited Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Glenmark Pharmaceuticals Limited Recent Developments/Updates
7.6.6 Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.7 lohnson and Johnson
7.7.1 lohnson and Johnson Details
7.7.2 lohnson and Johnson Major Business
7.7.3 lohnson and Johnson Expectorant Drug Product and Services
7.7.4 lohnson and Johnson Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 lohnson and Johnson Recent Developments/Updates
7.7.6 lohnson and Johnson Competitive Strengths & Weaknesses
7.8 Merck KGaA
7.8.1 Merck KGaA Details
7.8.2 Merck KGaA Major Business
7.8.3 Merck KGaA Expectorant Drug Product and Services
7.8.4 Merck KGaA Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Merck KGaA Recent Developments/Updates
7.8.6 Merck KGaA Competitive Strengths & Weaknesses
7.9 Novartis International AG
7.9.1 Novartis International AG Details
7.9.2 Novartis International AG Major Business
7.9.3 Novartis International AG Expectorant Drug Product and Services
7.9.4 Novartis International AG Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Novartis International AG Recent Developments/Updates
7.9.6 Novartis International AG Competitive Strengths & Weaknesses
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Details
7.10.2 Pfizer Inc. Major Business
7.10.3 Pfizer Inc. Expectorant Drug Product and Services
7.10.4 Pfizer Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Pfizer Inc. Recent Developments/Updates
7.10.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.11 Proctor and Gamble Co
7.11.1 Proctor and Gamble Co Details
7.11.2 Proctor and Gamble Co Major Business
7.11.3 Proctor and Gamble Co Expectorant Drug Product and Services
7.11.4 Proctor and Gamble Co Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Proctor and Gamble Co Recent Developments/Updates
7.11.6 Proctor and Gamble Co Competitive Strengths & Weaknesses
7.12 Reckitt Benckiser Group plc
7.12.1 Reckitt Benckiser Group plc Details
7.12.2 Reckitt Benckiser Group plc Major Business
7.12.3 Reckitt Benckiser Group plc Expectorant Drug Product and Services
7.12.4 Reckitt Benckiser Group plc Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Reckitt Benckiser Group plc Recent Developments/Updates
7.12.6 Reckitt Benckiser Group plc Competitive Strengths & Weaknesses
7.13 Sanofi SA
7.13.1 Sanofi SA Details
7.13.2 Sanofi SA Major Business
7.13.3 Sanofi SA Expectorant Drug Product and Services
7.13.4 Sanofi SA Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Sanofi SA Recent Developments/Updates
7.13.6 Sanofi SA Competitive Strengths & Weaknesses
7.14 The Himalaya Drug Company
7.14.1 The Himalaya Drug Company Details
7.14.2 The Himalaya Drug Company Major Business
7.14.3 The Himalaya Drug Company Expectorant Drug Product and Services
7.14.4 The Himalaya Drug Company Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 The Himalaya Drug Company Recent Developments/Updates
7.14.6 The Himalaya Drug Company Competitive Strengths & Weaknesses
7.15 Perrigo Company plc
7.15.1 Perrigo Company plc Details
7.15.2 Perrigo Company plc Major Business
7.15.3 Perrigo Company plc Expectorant Drug Product and Services
7.15.4 Perrigo Company plc Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Perrigo Company plc Recent Developments/Updates
7.15.6 Perrigo Company plc Competitive Strengths & Weaknesses
7.16 Vernalis plc
7.16.1 Vernalis plc Details
7.16.2 Vernalis plc Major Business
7.16.3 Vernalis plc Expectorant Drug Product and Services
7.16.4 Vernalis plc Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Vernalis plc Recent Developments/Updates
7.16.6 Vernalis plc Competitive Strengths & Weaknesses
7.17 Tris Pharma Inc.
7.17.1 Tris Pharma Inc. Details
7.17.2 Tris Pharma Inc. Major Business
7.17.3 Tris Pharma Inc. Expectorant Drug Product and Services
7.17.4 Tris Pharma Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Tris Pharma Inc. Recent Developments/Updates
7.17.6 Tris Pharma Inc. Competitive Strengths & Weaknesses
7.18 Aytu BioScience Inc.
7.18.1 Aytu BioScience Inc. Details
7.18.2 Aytu BioScience Inc. Major Business
7.18.3 Aytu BioScience Inc. Expectorant Drug Product and Services
7.18.4 Aytu BioScience Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Aytu BioScience Inc. Recent Developments/Updates
7.18.6 Aytu BioScience Inc. Competitive Strengths & Weaknesses
7.19 Mayne Pharma Inc.
7.19.1 Mayne Pharma Inc. Details
7.19.2 Mayne Pharma Inc. Major Business
7.19.3 Mayne Pharma Inc. Expectorant Drug Product and Services
7.19.4 Mayne Pharma Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Mayne Pharma Inc. Recent Developments/Updates
7.19.6 Mayne Pharma Inc. Competitive Strengths & Weaknesses
7.20 Taro Pharmaceutical Industries Ltd.
7.20.1 Taro Pharmaceutical Industries Ltd. Details
7.20.2 Taro Pharmaceutical Industries Ltd. Major Business
7.20.3 Taro Pharmaceutical Industries Ltd. Expectorant Drug Product and Services
7.20.4 Taro Pharmaceutical Industries Ltd. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
7.20.6 Taro Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.21 Amneal Pharmaceuticals LLC
7.21.1 Amneal Pharmaceuticals LLC Details
7.21.2 Amneal Pharmaceuticals LLC Major Business
7.21.3 Amneal Pharmaceuticals LLC Expectorant Drug Product and Services
7.21.4 Amneal Pharmaceuticals LLC Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
7.21.6 Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
7.22 Aurobindo Pharma Ltd
7.22.1 Aurobindo Pharma Ltd Details
7.22.2 Aurobindo Pharma Ltd Major Business
7.22.3 Aurobindo Pharma Ltd Expectorant Drug Product and Services
7.22.4 Aurobindo Pharma Ltd Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.22.5 Aurobindo Pharma Ltd Recent Developments/Updates
7.22.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
7.23 GlaxoSmithKline plc.
7.23.1 GlaxoSmithKline plc. Details
7.23.2 GlaxoSmithKline plc. Major Business
7.23.3 GlaxoSmithKline plc. Expectorant Drug Product and Services
7.23.4 GlaxoSmithKline plc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.23.5 GlaxoSmithKline plc. Recent Developments/Updates
7.23.6 GlaxoSmithKline plc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Expectorant Drug Industry Chain
8.2 Expectorant Drug Upstream Analysis
8.2.1 Expectorant Drug Core Raw Materials
8.2.2 Main Manufacturers of Expectorant Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Expectorant Drug Production Mode
8.6 Expectorant Drug Procurement Model
8.7 Expectorant Drug Industry Sales Model and Sales Channels
8.7.1 Expectorant Drug Sales Model
8.7.2 Expectorant Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Expectorant Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Expectorant Drug Production Value by Region (2019-2024) & (USD Million)
Table 3. World Expectorant Drug Production Value by Region (2025-2030) & (USD Million)
Table 4. World Expectorant Drug Production Value Market Share by Region (2019-2024)
Table 5. World Expectorant Drug Production Value Market Share by Region (2025-2030)
Table 6. World Expectorant Drug Production by Region (2019-2024) & (K Units)
Table 7. World Expectorant Drug Production by Region (2025-2030) & (K Units)
Table 8. World Expectorant Drug Production Market Share by Region (2019-2024)
Table 9. World Expectorant Drug Production Market Share by Region (2025-2030)
Table 10. World Expectorant Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Expectorant Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Expectorant Drug Major Market Trends
Table 13. World Expectorant Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Expectorant Drug Consumption by Region (2019-2024) & (K Units)
Table 15. World Expectorant Drug Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Expectorant Drug Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Expectorant Drug Producers in 2023
Table 18. World Expectorant Drug Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Expectorant Drug Producers in 2023
Table 20. World Expectorant Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Expectorant Drug Company Evaluation Quadrant
Table 22. World Expectorant Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Expectorant Drug Production Site of Key Manufacturer
Table 24. Expectorant Drug Market: Company Product Type Footprint
Table 25. Expectorant Drug Market: Company Product Application Footprint
Table 26. Expectorant Drug Competitive Factors
Table 27. Expectorant Drug New Entrant and Capacity Expansion Plans
Table 28. Expectorant Drug Mergers & Acquisitions Activity
Table 29. United States VS China Expectorant Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Expectorant Drug Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Expectorant Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Expectorant Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Expectorant Drug Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Expectorant Drug Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Expectorant Drug Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Expectorant Drug Production Market Share (2019-2024)
Table 37. China Based Expectorant Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Expectorant Drug Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Expectorant Drug Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Expectorant Drug Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Expectorant Drug Production Market Share (2019-2024)
Table 42. Rest of World Based Expectorant Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Expectorant Drug Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Expectorant Drug Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Expectorant Drug Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Expectorant Drug Production Market Share (2019-2024)
Table 47. World Expectorant Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Expectorant Drug Production by Type (2019-2024) & (K Units)
Table 49. World Expectorant Drug Production by Type (2025-2030) & (K Units)
Table 50. World Expectorant Drug Production Value by Type (2019-2024) & (USD Million)
Table 51. World Expectorant Drug Production Value by Type (2025-2030) & (USD Million)
Table 52. World Expectorant Drug Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Expectorant Drug Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Expectorant Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Expectorant Drug Production by Application (2019-2024) & (K Units)
Table 56. World Expectorant Drug Production by Application (2025-2030) & (K Units)
Table 57. World Expectorant Drug Production Value by Application (2019-2024) & (USD Million)
Table 58. World Expectorant Drug Production Value by Application (2025-2030) & (USD Million)
Table 59. World Expectorant Drug Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Expectorant Drug Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Laboratories Major Business
Table 63. Abbott Laboratories Expectorant Drug Product and Services
Table 64. Abbott Laboratories Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Abbott Laboratories Recent Developments/Updates
Table 66. Abbott Laboratories Competitive Strengths & Weaknesses
Table 67. Acella Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 68. Acella Pharmaceuticals LLC Major Business
Table 69. Acella Pharmaceuticals LLC Expectorant Drug Product and Services
Table 70. Acella Pharmaceuticals LLC Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Acella Pharmaceuticals LLC Recent Developments/Updates
Table 72. Acella Pharmaceuticals LLC Competitive Strengths & Weaknesses
Table 73. Astrazeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 74. Astrazeneca Plc. Major Business
Table 75. Astrazeneca Plc. Expectorant Drug Product and Services
Table 76. Astrazeneca Plc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Astrazeneca Plc. Recent Developments/Updates
Table 78. Astrazeneca Plc. Competitive Strengths & Weaknesses
Table 79. Cipla Limited Basic Information, Manufacturing Base and Competitors
Table 80. Cipla Limited Major Business
Table 81. Cipla Limited Expectorant Drug Product and Services
Table 82. Cipla Limited Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Cipla Limited Recent Developments/Updates
Table 84. Cipla Limited Competitive Strengths & Weaknesses
Table 85. Dabur India Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Dabur India Ltd Major Business
Table 87. Dabur India Ltd Expectorant Drug Product and Services
Table 88. Dabur India Ltd Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Dabur India Ltd Recent Developments/Updates
Table 90. Dabur India Ltd Competitive Strengths & Weaknesses
Table 91. Glenmark Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 92. Glenmark Pharmaceuticals Limited Major Business
Table 93. Glenmark Pharmaceuticals Limited Expectorant Drug Product and Services
Table 94. Glenmark Pharmaceuticals Limited Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Glenmark Pharmaceuticals Limited Recent Developments/Updates
Table 96. Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 97. lohnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 98. lohnson and Johnson Major Business
Table 99. lohnson and Johnson Expectorant Drug Product and Services
Table 100. lohnson and Johnson Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. lohnson and Johnson Recent Developments/Updates
Table 102. lohnson and Johnson Competitive Strengths & Weaknesses
Table 103. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 104. Merck KGaA Major Business
Table 105. Merck KGaA Expectorant Drug Product and Services
Table 106. Merck KGaA Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Merck KGaA Recent Developments/Updates
Table 108. Merck KGaA Competitive Strengths & Weaknesses
Table 109. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 110. Novartis International AG Major Business
Table 111. Novartis International AG Expectorant Drug Product and Services
Table 112. Novartis International AG Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Novartis International AG Recent Developments/Updates
Table 114. Novartis International AG Competitive Strengths & Weaknesses
Table 115. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Pfizer Inc. Major Business
Table 117. Pfizer Inc. Expectorant Drug Product and Services
Table 118. Pfizer Inc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Pfizer Inc. Recent Developments/Updates
Table 120. Pfizer Inc. Competitive Strengths & Weaknesses
Table 121. Proctor and Gamble Co Basic Information, Manufacturing Base and Competitors
Table 122. Proctor and Gamble Co Major Business
Table 123. Proctor and Gamble Co Expectorant Drug Product and Services
Table 124. Proctor and Gamble Co Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Proctor and Gamble Co Recent Developments/Updates
Table 126. Proctor and Gamble Co Competitive Strengths & Weaknesses
Table 127. Reckitt Benckiser Group plc Basic Information, Manufacturing Base and Competitors
Table 128. Reckitt Benckiser Group plc Major Business
Table 129. Reckitt Benckiser Group plc Expectorant Drug Product and Services
Table 130. Reckitt Benckiser Group plc Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Reckitt Benckiser Group plc Recent Developments/Updates
Table 132. Reckitt Benckiser Group plc Competitive Strengths & Weaknesses
Table 133. Sanofi SA Basic Information, Manufacturing Base and Competitors
Table 134. Sanofi SA Major Business
Table 135. Sanofi SA Expectorant Drug Product and Services
Table 136. Sanofi SA Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Sanofi SA Recent Developments/Updates
Table 138. Sanofi SA Competitive Strengths & Weaknesses
Table 139. The Himalaya Drug Company Basic Information, Manufacturing Base and Competitors
Table 140. The Himalaya Drug Company Major Business
Table 141. The Himalaya Drug Company Expectorant Drug Product and Services
Table 142. The Himalaya Drug Company Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. The Himalaya Drug Company Recent Developments/Updates
Table 144. The Himalaya Drug Company Competitive Strengths & Weaknesses
Table 145. Perrigo Company plc Basic Information, Manufacturing Base and Competitors
Table 146. Perrigo Company plc Major Business
Table 147. Perrigo Company plc Expectorant Drug Product and Services
Table 148. Perrigo Company plc Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Perrigo Company plc Recent Developments/Updates
Table 150. Perrigo Company plc Competitive Strengths & Weaknesses
Table 151. Vernalis plc Basic Information, Manufacturing Base and Competitors
Table 152. Vernalis plc Major Business
Table 153. Vernalis plc Expectorant Drug Product and Services
Table 154. Vernalis plc Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Vernalis plc Recent Developments/Updates
Table 156. Vernalis plc Competitive Strengths & Weaknesses
Table 157. Tris Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 158. Tris Pharma Inc. Major Business
Table 159. Tris Pharma Inc. Expectorant Drug Product and Services
Table 160. Tris Pharma Inc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Tris Pharma Inc. Recent Developments/Updates
Table 162. Tris Pharma Inc. Competitive Strengths & Weaknesses
Table 163. Aytu BioScience Inc. Basic Information, Manufacturing Base and Competitors
Table 164. Aytu BioScience Inc. Major Business
Table 165. Aytu BioScience Inc. Expectorant Drug Product and Services
Table 166. Aytu BioScience Inc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Aytu BioScience Inc. Recent Developments/Updates
Table 168. Aytu BioScience Inc. Competitive Strengths & Weaknesses
Table 169. Mayne Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 170. Mayne Pharma Inc. Major Business
Table 171. Mayne Pharma Inc. Expectorant Drug Product and Services
Table 172. Mayne Pharma Inc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Mayne Pharma Inc. Recent Developments/Updates
Table 174. Mayne Pharma Inc. Competitive Strengths & Weaknesses
Table 175. Taro Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 176. Taro Pharmaceutical Industries Ltd. Major Business
Table 177. Taro Pharmaceutical Industries Ltd. Expectorant Drug Product and Services
Table 178. Taro Pharmaceutical Industries Ltd. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 180. Taro Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 181. Amneal Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 182. Amneal Pharmaceuticals LLC Major Business
Table 183. Amneal Pharmaceuticals LLC Expectorant Drug Product and Services
Table 184. Amneal Pharmaceuticals LLC Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 185. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 186. Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
Table 187. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 188. Aurobindo Pharma Ltd Major Business
Table 189. Aurobindo Pharma Ltd Expectorant Drug Product and Services
Table 190. Aurobindo Pharma Ltd Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 191. Aurobindo Pharma Ltd Recent Developments/Updates
Table 192. GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table 193. GlaxoSmithKline plc. Major Business
Table 194. GlaxoSmithKline plc. Expectorant Drug Product and Services
Table 195. GlaxoSmithKline plc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 196. Global Key Players of Expectorant Drug Upstream (Raw Materials)
Table 197. Expectorant Drug Typical Customers
Table 198. Expectorant Drug Typical Distributors
LIST OF FIGURE
Figure 1. Expectorant Drug Picture
Figure 2. World Expectorant Drug Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Expectorant Drug Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Expectorant Drug Production (2019-2030) & (K Units)
Figure 5. World Expectorant Drug Average Price (2019-2030) & (US$/Unit)
Figure 6. World Expectorant Drug Production Value Market Share by Region (2019-2030)
Figure 7. World Expectorant Drug Production Market Share by Region (2019-2030)
Figure 8. North America Expectorant Drug Production (2019-2030) & (K Units)
Figure 9. Europe Expectorant Drug Production (2019-2030) & (K Units)
Figure 10. China Expectorant Drug Production (2019-2030) & (K Units)
Figure 11. Japan Expectorant Drug Production (2019-2030) & (K Units)
Figure 12. Expectorant Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 15. World Expectorant Drug Consumption Market Share by Region (2019-2030)
Figure 16. United States Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 17. China Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 18. Europe Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 19. Japan Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 20. South Korea Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 22. India Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Expectorant Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Expectorant Drug Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Expectorant Drug Markets in 2023
Figure 26. United States VS China: Expectorant Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Expectorant Drug Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Expectorant Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Expectorant Drug Production Market Share 2023
Figure 30. China Based Manufacturers Expectorant Drug Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Expectorant Drug Production Market Share 2023
Figure 32. World Expectorant Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Expectorant Drug Production Value Market Share by Type in 2023
Figure 34. Oral Solid
Figure 35. Oral Liquid
Figure 36. Inhalants
Figure 37. World Expectorant Drug Production Market Share by Type (2019-2030)
Figure 38. World Expectorant Drug Production Value Market Share by Type (2019-2030)
Figure 39. World Expectorant Drug Average Price by Type (2019-2030) & (US$/Unit)
Figure 40. World Expectorant Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Expectorant Drug Production Value Market Share by Application in 2023
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Expectorant Drug Production Market Share by Application (2019-2030)
Figure 46. World Expectorant Drug Production Value Market Share by Application (2019-2030)
Figure 47. World Expectorant Drug Average Price by Application (2019-2030) & (US$/Unit)
Figure 48. Expectorant Drug Industry Chain
Figure 49. Expectorant Drug Procurement Model
Figure 50. Expectorant Drug Sales Model
Figure 51. Expectorant Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World Expectorant Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Expectorant Drug Production Value by Region (2019-2024) & (USD Million)
Table 3. World Expectorant Drug Production Value by Region (2025-2030) & (USD Million)
Table 4. World Expectorant Drug Production Value Market Share by Region (2019-2024)
Table 5. World Expectorant Drug Production Value Market Share by Region (2025-2030)
Table 6. World Expectorant Drug Production by Region (2019-2024) & (K Units)
Table 7. World Expectorant Drug Production by Region (2025-2030) & (K Units)
Table 8. World Expectorant Drug Production Market Share by Region (2019-2024)
Table 9. World Expectorant Drug Production Market Share by Region (2025-2030)
Table 10. World Expectorant Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Expectorant Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Expectorant Drug Major Market Trends
Table 13. World Expectorant Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Expectorant Drug Consumption by Region (2019-2024) & (K Units)
Table 15. World Expectorant Drug Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Expectorant Drug Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Expectorant Drug Producers in 2023
Table 18. World Expectorant Drug Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Expectorant Drug Producers in 2023
Table 20. World Expectorant Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Expectorant Drug Company Evaluation Quadrant
Table 22. World Expectorant Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Expectorant Drug Production Site of Key Manufacturer
Table 24. Expectorant Drug Market: Company Product Type Footprint
Table 25. Expectorant Drug Market: Company Product Application Footprint
Table 26. Expectorant Drug Competitive Factors
Table 27. Expectorant Drug New Entrant and Capacity Expansion Plans
Table 28. Expectorant Drug Mergers & Acquisitions Activity
Table 29. United States VS China Expectorant Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Expectorant Drug Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Expectorant Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Expectorant Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Expectorant Drug Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Expectorant Drug Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Expectorant Drug Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Expectorant Drug Production Market Share (2019-2024)
Table 37. China Based Expectorant Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Expectorant Drug Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Expectorant Drug Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Expectorant Drug Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Expectorant Drug Production Market Share (2019-2024)
Table 42. Rest of World Based Expectorant Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Expectorant Drug Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Expectorant Drug Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Expectorant Drug Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Expectorant Drug Production Market Share (2019-2024)
Table 47. World Expectorant Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Expectorant Drug Production by Type (2019-2024) & (K Units)
Table 49. World Expectorant Drug Production by Type (2025-2030) & (K Units)
Table 50. World Expectorant Drug Production Value by Type (2019-2024) & (USD Million)
Table 51. World Expectorant Drug Production Value by Type (2025-2030) & (USD Million)
Table 52. World Expectorant Drug Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Expectorant Drug Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Expectorant Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Expectorant Drug Production by Application (2019-2024) & (K Units)
Table 56. World Expectorant Drug Production by Application (2025-2030) & (K Units)
Table 57. World Expectorant Drug Production Value by Application (2019-2024) & (USD Million)
Table 58. World Expectorant Drug Production Value by Application (2025-2030) & (USD Million)
Table 59. World Expectorant Drug Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Expectorant Drug Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Laboratories Major Business
Table 63. Abbott Laboratories Expectorant Drug Product and Services
Table 64. Abbott Laboratories Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Abbott Laboratories Recent Developments/Updates
Table 66. Abbott Laboratories Competitive Strengths & Weaknesses
Table 67. Acella Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 68. Acella Pharmaceuticals LLC Major Business
Table 69. Acella Pharmaceuticals LLC Expectorant Drug Product and Services
Table 70. Acella Pharmaceuticals LLC Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Acella Pharmaceuticals LLC Recent Developments/Updates
Table 72. Acella Pharmaceuticals LLC Competitive Strengths & Weaknesses
Table 73. Astrazeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 74. Astrazeneca Plc. Major Business
Table 75. Astrazeneca Plc. Expectorant Drug Product and Services
Table 76. Astrazeneca Plc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Astrazeneca Plc. Recent Developments/Updates
Table 78. Astrazeneca Plc. Competitive Strengths & Weaknesses
Table 79. Cipla Limited Basic Information, Manufacturing Base and Competitors
Table 80. Cipla Limited Major Business
Table 81. Cipla Limited Expectorant Drug Product and Services
Table 82. Cipla Limited Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Cipla Limited Recent Developments/Updates
Table 84. Cipla Limited Competitive Strengths & Weaknesses
Table 85. Dabur India Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Dabur India Ltd Major Business
Table 87. Dabur India Ltd Expectorant Drug Product and Services
Table 88. Dabur India Ltd Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Dabur India Ltd Recent Developments/Updates
Table 90. Dabur India Ltd Competitive Strengths & Weaknesses
Table 91. Glenmark Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 92. Glenmark Pharmaceuticals Limited Major Business
Table 93. Glenmark Pharmaceuticals Limited Expectorant Drug Product and Services
Table 94. Glenmark Pharmaceuticals Limited Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Glenmark Pharmaceuticals Limited Recent Developments/Updates
Table 96. Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
Table 97. lohnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 98. lohnson and Johnson Major Business
Table 99. lohnson and Johnson Expectorant Drug Product and Services
Table 100. lohnson and Johnson Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. lohnson and Johnson Recent Developments/Updates
Table 102. lohnson and Johnson Competitive Strengths & Weaknesses
Table 103. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 104. Merck KGaA Major Business
Table 105. Merck KGaA Expectorant Drug Product and Services
Table 106. Merck KGaA Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Merck KGaA Recent Developments/Updates
Table 108. Merck KGaA Competitive Strengths & Weaknesses
Table 109. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 110. Novartis International AG Major Business
Table 111. Novartis International AG Expectorant Drug Product and Services
Table 112. Novartis International AG Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Novartis International AG Recent Developments/Updates
Table 114. Novartis International AG Competitive Strengths & Weaknesses
Table 115. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Pfizer Inc. Major Business
Table 117. Pfizer Inc. Expectorant Drug Product and Services
Table 118. Pfizer Inc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Pfizer Inc. Recent Developments/Updates
Table 120. Pfizer Inc. Competitive Strengths & Weaknesses
Table 121. Proctor and Gamble Co Basic Information, Manufacturing Base and Competitors
Table 122. Proctor and Gamble Co Major Business
Table 123. Proctor and Gamble Co Expectorant Drug Product and Services
Table 124. Proctor and Gamble Co Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Proctor and Gamble Co Recent Developments/Updates
Table 126. Proctor and Gamble Co Competitive Strengths & Weaknesses
Table 127. Reckitt Benckiser Group plc Basic Information, Manufacturing Base and Competitors
Table 128. Reckitt Benckiser Group plc Major Business
Table 129. Reckitt Benckiser Group plc Expectorant Drug Product and Services
Table 130. Reckitt Benckiser Group plc Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Reckitt Benckiser Group plc Recent Developments/Updates
Table 132. Reckitt Benckiser Group plc Competitive Strengths & Weaknesses
Table 133. Sanofi SA Basic Information, Manufacturing Base and Competitors
Table 134. Sanofi SA Major Business
Table 135. Sanofi SA Expectorant Drug Product and Services
Table 136. Sanofi SA Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Sanofi SA Recent Developments/Updates
Table 138. Sanofi SA Competitive Strengths & Weaknesses
Table 139. The Himalaya Drug Company Basic Information, Manufacturing Base and Competitors
Table 140. The Himalaya Drug Company Major Business
Table 141. The Himalaya Drug Company Expectorant Drug Product and Services
Table 142. The Himalaya Drug Company Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. The Himalaya Drug Company Recent Developments/Updates
Table 144. The Himalaya Drug Company Competitive Strengths & Weaknesses
Table 145. Perrigo Company plc Basic Information, Manufacturing Base and Competitors
Table 146. Perrigo Company plc Major Business
Table 147. Perrigo Company plc Expectorant Drug Product and Services
Table 148. Perrigo Company plc Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Perrigo Company plc Recent Developments/Updates
Table 150. Perrigo Company plc Competitive Strengths & Weaknesses
Table 151. Vernalis plc Basic Information, Manufacturing Base and Competitors
Table 152. Vernalis plc Major Business
Table 153. Vernalis plc Expectorant Drug Product and Services
Table 154. Vernalis plc Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Vernalis plc Recent Developments/Updates
Table 156. Vernalis plc Competitive Strengths & Weaknesses
Table 157. Tris Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 158. Tris Pharma Inc. Major Business
Table 159. Tris Pharma Inc. Expectorant Drug Product and Services
Table 160. Tris Pharma Inc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Tris Pharma Inc. Recent Developments/Updates
Table 162. Tris Pharma Inc. Competitive Strengths & Weaknesses
Table 163. Aytu BioScience Inc. Basic Information, Manufacturing Base and Competitors
Table 164. Aytu BioScience Inc. Major Business
Table 165. Aytu BioScience Inc. Expectorant Drug Product and Services
Table 166. Aytu BioScience Inc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Aytu BioScience Inc. Recent Developments/Updates
Table 168. Aytu BioScience Inc. Competitive Strengths & Weaknesses
Table 169. Mayne Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 170. Mayne Pharma Inc. Major Business
Table 171. Mayne Pharma Inc. Expectorant Drug Product and Services
Table 172. Mayne Pharma Inc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Mayne Pharma Inc. Recent Developments/Updates
Table 174. Mayne Pharma Inc. Competitive Strengths & Weaknesses
Table 175. Taro Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 176. Taro Pharmaceutical Industries Ltd. Major Business
Table 177. Taro Pharmaceutical Industries Ltd. Expectorant Drug Product and Services
Table 178. Taro Pharmaceutical Industries Ltd. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 180. Taro Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 181. Amneal Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 182. Amneal Pharmaceuticals LLC Major Business
Table 183. Amneal Pharmaceuticals LLC Expectorant Drug Product and Services
Table 184. Amneal Pharmaceuticals LLC Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 185. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 186. Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
Table 187. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 188. Aurobindo Pharma Ltd Major Business
Table 189. Aurobindo Pharma Ltd Expectorant Drug Product and Services
Table 190. Aurobindo Pharma Ltd Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 191. Aurobindo Pharma Ltd Recent Developments/Updates
Table 192. GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table 193. GlaxoSmithKline plc. Major Business
Table 194. GlaxoSmithKline plc. Expectorant Drug Product and Services
Table 195. GlaxoSmithKline plc. Expectorant Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 196. Global Key Players of Expectorant Drug Upstream (Raw Materials)
Table 197. Expectorant Drug Typical Customers
Table 198. Expectorant Drug Typical Distributors
LIST OF FIGURE
Figure 1. Expectorant Drug Picture
Figure 2. World Expectorant Drug Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Expectorant Drug Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Expectorant Drug Production (2019-2030) & (K Units)
Figure 5. World Expectorant Drug Average Price (2019-2030) & (US$/Unit)
Figure 6. World Expectorant Drug Production Value Market Share by Region (2019-2030)
Figure 7. World Expectorant Drug Production Market Share by Region (2019-2030)
Figure 8. North America Expectorant Drug Production (2019-2030) & (K Units)
Figure 9. Europe Expectorant Drug Production (2019-2030) & (K Units)
Figure 10. China Expectorant Drug Production (2019-2030) & (K Units)
Figure 11. Japan Expectorant Drug Production (2019-2030) & (K Units)
Figure 12. Expectorant Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 15. World Expectorant Drug Consumption Market Share by Region (2019-2030)
Figure 16. United States Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 17. China Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 18. Europe Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 19. Japan Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 20. South Korea Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 22. India Expectorant Drug Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Expectorant Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Expectorant Drug Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Expectorant Drug Markets in 2023
Figure 26. United States VS China: Expectorant Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Expectorant Drug Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Expectorant Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Expectorant Drug Production Market Share 2023
Figure 30. China Based Manufacturers Expectorant Drug Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Expectorant Drug Production Market Share 2023
Figure 32. World Expectorant Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Expectorant Drug Production Value Market Share by Type in 2023
Figure 34. Oral Solid
Figure 35. Oral Liquid
Figure 36. Inhalants
Figure 37. World Expectorant Drug Production Market Share by Type (2019-2030)
Figure 38. World Expectorant Drug Production Value Market Share by Type (2019-2030)
Figure 39. World Expectorant Drug Average Price by Type (2019-2030) & (US$/Unit)
Figure 40. World Expectorant Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Expectorant Drug Production Value Market Share by Application in 2023
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Expectorant Drug Production Market Share by Application (2019-2030)
Figure 46. World Expectorant Drug Production Value Market Share by Application (2019-2030)
Figure 47. World Expectorant Drug Average Price by Application (2019-2030) & (US$/Unit)
Figure 48. Expectorant Drug Industry Chain
Figure 49. Expectorant Drug Procurement Model
Figure 50. Expectorant Drug Sales Model
Figure 51. Expectorant Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
